Romedahl MedScience ApS: Financial statements 2021
CVR: 38540580
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Romedahl MedScience ApS (CVR 38540580) has filed annual accounts for 2021. In 2021, the company reported a net result of DKK -7,940 compared with DKK -8,933 the year before. Equity in the 2021 report amounted to DKK 26,626. The solvency ratio was 78.6%. The company had 1 employee in the financial year.
- Profit/Loss
- DKK -7,940
- Equity
- DKK 26,626
- Total Assets
- DKK 33,877
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | - | -8K | 27K | 1 |
| 2020 | - | - | -9K | -5K | 1 |
| 2019 | - | 0 | 0 | 4K | 0 |
| 2018 | 0 | 0 | 0 | 4K | - |
Official annual report
Find more companies like Romedahl MedScience ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
On October 11, 2021, the company changed its name from Romedahl MedScience IVS to Romedahl MedScience ApS.
Romedahl MedScience ApS has published its annual report for 2020. The net result was DKK -8,933.
About Romedahl MedScience ApS
Romedahl MedScience ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2017. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named Romedahl MedScience IVS. The management consists of Hanne Risager Romedahl. The company is owned by Hanne Risager Romedahl. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK -8,552 compared with DKK -6,398 the year before. Equity in the 2025 report amounted to DKK 642.